Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 

Consuming illicit opioids during a drug overdose epidemic: Illicit fentanyls, drug discernment, and the radical transformation of the illicit opioid market

This qualitative study was conducted to better understand how people who inject drugs (PWID) came to recognize fentanyl as a growing adulterant of heroin and the subsequent sensory discernment strateg
Original research | 2022
Harm reduction, About PWUD, Illegal drugs, Stimulants

Detecting risk level in individuals misusing fentanyl utilizing posts from an online community on Reddit

Because those who misuse fentanyl are often a hidden and high risk group, innovative methods for identifying individuals at risk for fentanyl misuse are needed.
Original research | 2021
Harm reduction, Illegal drugs, Digital health

Emergency Department–Initiated Buprenorphine/Naloxone Treatment for Opioid Dependence: A Randomized Clinical Trial

To test the efficacy of 3 interventions for opioid dependence: (1) screening and referral to treatment (referral); (2) screening, brief intervention, and facilitated referral to community-based treatm
Original research | 2015
About prescribers, Outcomes, Illegal drugs, Substitution/OAT, Transitions in care/treatment, Hospitals

Going Nowhere: Ambivalence about Drug Treatment during an Overdose Public Health Emergency in Vancouver

The declaration of an overdose public health emergency in Vancouver has generated an “affective churn” of intervention across youth‐focused drug treatment settings, including the expanded provision of
Original research | 2021
Wrap-around services, About PWUD, Social services, Housing, Illegal drugs, Youth, Indigenous, Substitution/OAT

Perceived healthcare stigma among patients in opioid substitution treatment: a qualitative study

To explore OST patients’ past and present experiences of substance use stigma in healthcare settings
Original research | 2021
Barriers and enablers, Stigma

Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection

While opioid agonist therapy (OAT) reduces the risk of hepatitis C virus (HCV) acquisition among people who inject drugs (PWID), protective effects may be attenuated in females.
Original research | 2020
Harm reduction, Advocacy, Outcomes, Sex/Gender

Stimulant safe supply: a potential opportunity to respond to the overdose epidemic

Commentary | 2020
Safer supply, Equity, Barriers and enablers, Poverty, Stimulants, Peer/PWLLE program involvement

Supervised consumption services for acute care hospital patients

Commentary | 2020
Harm reduction, Policy/Regulatory, About prescribers, Illegal drugs, Stigma, SCS/OPS, Hospitals

The DULF Compassion Club project

Archived webinar | 2021
Harm reduction, Policy/Regulatory, Safer supply, Decriminalization/legalization, Advocacy, About PWUD, Illegal drugs

The essential role of pharmacists in the opioid crisis

Support pharmacists in naloxone provision, overdose prevention, etc.

Commentary | 2017
Overdose, Hesitancy of prescribers , About pharmacists

The impact of the Sydney Medically Supervised Injecting Centre (MSIC) on crime

Aimed to model the effect of Australia's first Medically Supervised Injecting Centre (MSIC) on acquisitive crime and loitering by drug users and dealers
Original research | 2009
Crime, Illegal drugs, SCS/OPS

The implications of COVID-19 for people who use drugs (PWUD)

Highlight emerging risks linked to the COVID-19 pandemic for people who use drugs and those providing services for them from a European perspective, and encourages the planning, review and adaption of
Commentary | 2020
Harm reduction, About PWUD, Illegal drugs

The opioid death crisis in Canada: crucial lessons for public health

Look at public health lessons from the opioid crisis
Commentary | 2018
Mortality, Withdrawal, Evidence base, Policy/Regulatory, Advocacy, Illegal drugs

The release of abuse-deterrent OxyContin and adolescent heroin use

To determine the association between the abuse-deterrent reformulation of OxyContin and adolescent lifetime heroin use in the United States.
Original research | 2021
Evidence base, Illegal drugs, Youth

The State of Opioid Agonist Therapy in Canada 20 Years after Federal Oversight

During the more than 20 years since the federal health authority transferred oversight of methadone to the provincial level, methadone programming has evolved differently in every province
Commentary | 2017
Evidence base, Policy/Regulatory, Wrap-around services, Safer supply, Rural/remote, Substitution/OAT

The Structure, Growth, and Development of an Addiction Medicine & Rural Service

Slide deck | 2021
Clinical guidance, About prescribers, Small/medium cities

Trained Volunteers With Type 2 Diabetes Experience Significant Health Benefits When Providing Peer Support

Trained lay volunteers may have value in supporting lifestyle change programs in the prevention of type 2 diabetes, but the potential health benefits (or harms) experienced by these lay volunteers hav
Original research | 2021
Peer/PWLLE program involvement

‘Keeping a lid on it’: Exploring ‘problematisations’ of prescribed medication in prisons in the UK

The non-medical use of prescription medication and risk of diversion have become policy and practice concerns within prison settings in the UK.
Original research | 2022
Policy/Regulatory, Advocacy, About prescribers, Legal system/law enforcement, Diversion

‘Safer opioid distribution’ as an essential public health intervention for the opioid mortality crisis – Considerations, options and examples towards broad-based implementation

Commentary | 2020
Harm reduction, Policy/Regulatory, Safer supply

Advocating for diamorphine: Cosmopolitical care and collective action in the ruins of the ‘old British system’

Argue through the accounts of advocates and patients for the continuation of these flexible and hidden modes of caring with diamorphine as not merely a form of supporting individuals’ rights (to ca

Original research | 2020
Policy/Regulatory, Advocacy, Barriers and enablers

Affiner votre recherche

Mots clés
Format
Région